EUVIMEDEUVIMED entdecken
Systematische ÜbersichtMetaanalyse

The Role of Long Non-Coding RNAs in Prostate Cancer Progression: A Systematic Review and Meta-Analysis

Celestine O. Ogbu, Daniel Uti, Emmanuel Ochube, Agnes Ebesi, Patrick Aja

Tropical Journal of Medicine and Basic Sciences · 15.11.2025

DOI: 10.1234/6m7zm679 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Tropical Journal of Medicine and Basic Sciences, erschienen am 15.11.2025. Verfasst von Celestine O. Ogbu und 4 weiteren Autor:innen.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Context

Prostate cancer (PCa) is a leading cause of cancer morbidity and mortality worldwide. Long non-coding RNAs (lncRNAs) have been implicated in cancer biology, but their prognostic role in PCa remains uncertain.

Objective

To systematically synthesize global evidence on the association between lncRNA expression and prostate cancer progression.

Methods

Following PRISMA guidelines, PubMed, Web of Science, and Scopus were searched through October 2024 for human studies reporting lncRNA expression with survival outcomes. Studies lacking sufficient statistical data, non-original reports, or animal studies without mechanistic insights translatable to human PCa were excluded. Data extraction and quality assessment (Newcastle–Ottawa Scale) were performed; pooled hazard ratios (HRs) and heterogeneity (I²) were reported.

Results

Of 603 records screened, 31 studies met eligibility criteria. Pooled analysis of overall survival (OS) from 27 studies (n=2,807) yielded HR = 1.17 (95% CI: 0.92–1.49; I² = 89.3%), which is not statistically significant (P=0.192) and is accompanied by substantial heterogeneity. Disease-free survival (DFS) pooled from 3 studies (n=358) showed HR = 0.72 (95% CI: 0.62–1.84; I² = 69.0); the confidence interval crosses 1, and the analysis is underpowered. High between-study heterogeneity and small study numbers limit the certainty of pooled estimates. No eligible studies from Africa or Nigeria were identified, highlighting a regional evidence gap.

Conclusions

Current evidence provides suggestive but not conclusive evidence that dysregulated lncRNAs may be associated with prostate cancer outcomes. Small effect sizes, wide confidence intervals, and substantial heterogeneity mean these results should be interpreted cautiously.

Schlagwörter

long non-coding RNAprostate cancertumor progressionprognostic factorsoverall survivaldisease-free survivallncRNA expressionsurvival outcomes

Zitieren

APA

Ogbu, C. O., Uti, D., Ochube, E., Ebesi, A., & Aja, P. (2025). The Role of Long Non-Coding RNAs in Prostate Cancer Progression: A Systematic Review and Meta-Analysis. Tropical Journal of Medicine and Basic Sciences. https://doi.org/10.1234/6m7zm679

Vancouver

Ogbu CO, Uti D, Ochube E, Ebesi A, Aja P. The Role of Long Non-Coding RNAs in Prostate Cancer Progression: A Systematic Review and Meta-Analysis. Tropical Journal of Medicine and Basic Sciences. 2025. doi:10.1234/6m7zm679

BibTeX
@article{Ogbu2025,
  author = {Ogbu, Celestine O. and Uti, Daniel and Ochube, Emmanuel and Ebesi, Agnes and Aja, Patrick},
  title = {The Role of Long Non-Coding RNAs in Prostate Cancer Progression: A Systematic Review and Meta-Analysis},
  journal = {Tropical Journal of Medicine and Basic Sciences},
  year = {2025},
  doi = {10.1234/6m7zm679}
}
Kostenlos starten →